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36.2, vs. 45.5, P < 0.001), and had lower baseline viremia
(mean 1.014× 106 IU/mL vs. 2.415× 106 IU/mL, P < 0.001).
SVR was more frequent in women than in men (43/63, 62.8%
vs. 62/116, 53.4%) (P = 0.059).
Conclusion: 1) Negative serum HCV RNA at week 12 is
more predictive of SVR than EVR. 2) The probability of
SVR was signiﬁcantly higher in patients with lower baseline
viremia, body weight and younger adults. 3) Gender was not
signiﬁcant for the efﬁcacy of treatment.
doi:10.1016/j.ijid.2008.05.1107
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Hepatitis C virus (HCV) major public health concerns in
Pakistan. A molecular study was conducted to investigate
the prevalence of Hepatitis C Genotype 3a in the infected
population of Metropolitan. By using primers against the 5′
non coding region of the viral RNA was reverse transcribed
into cDNA and for qualitative analysis, the ampliﬁcation of
cDNA was done by ﬁrst round PCR. Nested PCR was per-
formed with ﬁrst round PCR product. Ampliﬁcation of HCV
cDNA for genotyping by regular PCR was carried out. For HCV
genotyping second round PCR, two different primer mixtures
were prepared. Detection of genotype speciﬁc bandwas per-
formed through gel electrophoresis. 232 bp speciﬁc band of
HCV 3a genotype was determined by comparing with 100
bp DNA size of marker. Our result showed, out of 28 HCV
PCR positive samples, ﬁfteen samples have HCV genotype
3a. The prevalence of genotype 3a HCV RNA was found to
be 55% in local population of Lahore.
doi:10.1016/j.ijid.2008.05.1108
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One of the most frequent reasons of hepatitis is HCV virus
infection. There are two methods of infection detection:
immunological and genetic ones.
The study was made on 361 patients with the features
of liver pathology admitted to the Clinic during the years
of 2000—2004. Besides standard methods aimed to deter-
mine disease aetiology and the level of liver damage, the
blood serum tests were made simultaneously. There were
as follows: detection of anti-HCV antibodies by the quality
method Architekt System; Innogenetics test as the conﬁr-
mation test, and detection of RNA-virus by PCR method,
Cobas Amplicor 2.0 test. The tested population underwent
outpatient observation for at least six months.
The anti-HCV antibodies were detected among 256
patients, RNA-virus was detected among 212 patients.
The results of both of these tests were negative for 102
patients and positive for 209 patients. The RNA-virus was not
detected among 47 patients with presence of the anti-HCV
antibodies. The RNA-virus was detected for three patients
without presence of the anti-HCV antibodies. The following
observation and performing the tests such as liver biopsy led
to diagnose hepatitis virus infection among all the patients
with detected at least single infection marker. Four patients
were diagnosed as the acute infection cases and 255 as
chronic infection cases. The following next months’ obser-
vation did not led to detect any changes for the infection
status of patients without infection markers.
The detection of the anti-HCV antibodies in the blood
serum with the third-generation tests should be treated as
the standard procedure in the liver infection diagnosis.
The detection of HCV RNA can be reasonable in the
following cases: suspected acute HCV infection, unclear
clinical picture; particularly when the possibility of infection
related claims occur, drug addicts and patients suspected for
taking drugs, review of antiviral therapy effectiveness.
doi:10.1016/j.ijid.2008.05.1235
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Background: Genomic mutations presented during hep-
atitis B virus (HBV) reverse transcription could explain its
genetic diversity and account for genetically distinct eight
genotypes which show distinctive geographically distribu-
tion. The main objectives of this study were to determinate
the prevalence of hepatitis B virus genotypes in patients with
chronic hepatitis B, and to look for a relationship between
genotypes and risk transmission factors according to HBeAg
state.
Patients and methods: A total of 14 serum samples from
chronic HBV patients were analysed using INNO-LIPA HBV
Genotyping assay (Innogenetics). The presence of mixed
genotype infection was veriﬁed by sequencing using the
BigDye Terminator Cycle Sequencing Kit on an ABI Prism 3130
Genetic Analyzer. Hepatitis B virus HBsAg, anti-HBs, HBeAg
and anti-HBe were determined by ADVIA Centaur (Bayer).
Results: Genotype D was the most prevalent (64.3%)
followed by genotype A (28.6%). There was a coinfection
case (D/E genotypes) that was conﬁrmed by sequencing PCR
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product. All patients except one were HBeAg-negative and
anti-HBe-positive. The only patients with HBeAg-positive
showed genotype D and had a previously seroconversion
but latter had a new reactivation. About risk factors for
HBV acquisition, in half of cases was unknown; in the other
half there was sexual (21.4%), transfusion (14.3%), maternal
(7.1%) or interfamilial (7.1%) transmission.
Conclusions: These result showed that genotype D is the
most prevalent accompanied with genotype A in chronically
infected patients in our hospital. Moreover, we did not found
any evidence about HBeAg state and identiﬁed genotype.
doi:10.1016/j.ijid.2008.05.1236
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Background: HCV comprises a heterogeneous family of
viruses, with at least six genotypes and countless subtypes.
HCV infection is a public health problem worldwide, includ-
ing in Brazil. The World Health Organization estimates that
approximately 3% of the Brazilian population is infected
with HCV. Identiﬁcation of the HCV genotype is important
for epidemiology, prognosis, and determining the course of
treatment for the infection; there is data that suggests a
poorer prognosis and the need for more aggressive therapy
for genotype 1.
Objective: Determine the prevalence of different HCV
genotypes in the population of the city of Brasilia, the
national capital.
Methods: A retrospective, cross-sectional study was con-
ducted with a population of 213 individuals, comprising
128 men and 85 women between the ages of 21 and 81,
who underwent genotyping for HCV in Sabin laboratories
between 2005 and 2007. Repeat cases were excluded from
the study. Detection of viral RNA in the plasma was obtained
by the nested-RT-PCR technique and genotyping by the RFLP
technique.
Results and Conclusion: Genotype 1 was observed in 149
individuals (70%), genotype 3 in 53 individuals (25%), geno-
type 2 in 9 individuals (4%), and genotype 4 in 2 individuals
(1%). Subtypes 5 and 6 were not found in this population.
The results obtained in the Federal District population are
similar to those published in other states in the Southeast
and Northeast regions of Brazil and to the distribution of
HCV genotypes in the western world.
doi:10.1016/j.ijid.2008.05.1237
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Background: About, two billion people in the world have
been infected by Hepatitis B virus (HBV), 350 million of
whom are chronic carriers of the virus. Occult hepatitis
B virus (HBV) infection is characterized by presence of
HBV infection with undetectable hepatitis B surface antigen
(HBsAg). Diagnosis of occult HBV infection requires sensi-
tive HBV-DNA polymerase chain reaction (PCR)assay. Scanty
information is available about the etiology of viral chronic
diseases in the United Arab Emirates (UAE). Therefore a
study was carried out for detecting and genotyping of Hep-
atitis B Virus (HBV) in patients with chronic liver diseases
(CLD) as well as determining the prevalence of occult HBV
in CLD patients in the UAE.
Methods: A total of 248 serum samples from CLD patients
and 139 healthy individuals were tested by polymerase
chain reaction (PCR) in determining DNA in serum samples.
Liver biopsies were taken from randomly selected 71 HBV
infection from CLD patients were tested by immunohisto-
chemistry ((IHC) staining for HBsAg and HBcAg. Genotyping
of HBV-DNA was carried out by commercial kit.
Results: The results indicated the prevalence of HCV,
HBV, Mixed (HBV & HCV) and Occult HBV infections at a
rate of 51.2%, 31.8%, 4.0%, and 8.9% in CLD patients respec-
tively. On the other hand Healthy subjects were found to be
positive for HBV at a rate of 2.9% (P = 0.001). Themost preva-
lent genotypes of HBV infection in CLD patients were D and
E (60.6% & 26.8.0% respectively). Whereas the prevalence
of other genotypes (B, C and A) were in the range of 3.8%,
1.9% and 0.9% respectively. IHC results of randomly selected
71 CLD patients with HBV revealed that 98.6% (70/71), of
the liver biopsies were positive for HbsAg & HbcAg whereas
95.8% (68/71) of the serum samples and liver biopsies among
occult HBV patients with CLD were positive for HBV-DNA
by PCR. Histopathological studies of liver biopsies revealed
that patients with HBV infection were more likely to have
necroinﬂammatory activity and ﬁbrosis than patients with-
out HBV infection.
Conclusion: Occult HBV is relatively frequent among
patients with CLD in UAE. It may be associated with
more advanced liver pathology and more aggressive clinical
course. Genotype D appears to be the dominant genotype
circulating in UAE population with CLD. Genotypes C and
A appeared to be the minor genotypes. IHC staining could
be of a help in the diagnosis of occult HBV in CLD patients
beside PCR.
doi:10.1016/j.ijid.2008.05.1238
